Neoplas

Greifswald, Germany Founded: 2005 • Age: 21 yrs
Provider of cold plasma technology for gentle wound therapy in veterinary medicine
Request Access

About Neoplas

Neoplas is a company based in Greifswald (Germany) founded in 2005.. Neoplas offers products and services including kINPen® VET. Neoplas operates in a competitive market with competitors including Welch Allyn, Kubanda Cryotherapy, IntegriMedical, Vetbiolix and PulseVet, among others.

  • Headquarter Greifswald, Germany
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Neoplas Gmbh
Operational Areas
Healthcare → Veterinary & Animal Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $55.82 K (USD), Grant

    Apr 30, 2019

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Neoplas

Neoplas offers a comprehensive portfolio of products and services, including kINPen® VET. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Uses cold plasma to inactivate pathogens and stimulate animal tissue regeneration.

Funding Insights of Neoplas

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $55,824
  • First Round

    (30 Apr 2019)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2019 Amount Grant - Neoplas Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Neoplas

Neoplas has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Neoplas

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Neoplas

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Neoplas Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Neoplas

Neoplas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Welch Allyn, Kubanda Cryotherapy, IntegriMedical, Vetbiolix and PulseVet, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provides smart beds, patient monitoring, and care communications for healthcare facilities.
domain founded_year HQ Location
Cryotherapy devices for treating pet cancer are provided.
domain founded_year HQ Location
Needle-free injection systems for pets are developed.
domain founded_year HQ Location
Develops first-in-class drugs for pet conditions including periodontitis and osteoarthritis.
domain founded_year HQ Location
Developer of sound wave based device for pain management
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Neoplas

Frequently Asked Questions about Neoplas

When was Neoplas founded?

Neoplas was founded in 2005 and raised its 1st funding round 14 years after it was founded.

Where is Neoplas located?

Neoplas is headquartered in Greifswald, Germany. It is registered at Greifswald, Mecklenburg-vorpommern, Germany.

Who is the current CEO of Neoplas?

Ulrike Sailer is the current CEO of Neoplas.

What does Neoplas do?

Provider of cold plasma technology for gentle wound therapy in veterinary medicine. The company offers cold plasma jet kINPen VET that can be applied in a wide range of indications, such as dermatological diseases, acute and chronic wounds.

Who are the top competitors of Neoplas?

Neoplas's top competitors include Kubanda Cryotherapy, IntegriMedical and Jeshron Biotech Solutions.

What products or services does Neoplas offer?

Neoplas offers kINPen® VET.

Who are Neoplas's investors?

Neoplas has 1 investor. Key investors include EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available